Skip to main navigation Skip to search Skip to main content

Reduction in erythrocyte-bound complement activation products and titres of anti-C1q antibodies associate with clinical improvement in systemic lupus erythematosus

  • Jill Buyon
  • , Richard Furie
  • , Chaim Putterman
  • , Rosalind Ramsey-Goldman
  • , Kenneth Kalunian
  • , Derren Barken
  • , John Conklin
  • , Thierry Dervieux
  • New York University
  • Hofstra Northwell School of Medicine
  • Albert Einstein College of Medicine
  • Northwestern University
  • University of California at San Diego
  • Exagen Inc

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Fingerprint

Dive into the research topics of 'Reduction in erythrocyte-bound complement activation products and titres of anti-C1q antibodies associate with clinical improvement in systemic lupus erythematosus'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Immunology and Microbiology

Keyphrases